Search hospitals > Florida > Orlando
AdventHealth Orlando
Claim this profileOrlando, Florida 32803
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Brain Tumor
Conducts research for Ovarian Cancer
658 reported clinical trials
43 medical researchers
Summary
AdventHealth Orlando is a medical facility located in Orlando, Florida. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Brain Tumor, Ovarian Cancer and other specialties. AdventHealth Orlando is involved with conducting 658 clinical trials across 903 conditions. There are 43 research doctors associated with this hospital, such as Fouad M. Hajjar, Carlos Alemany, Mohamedtaki A. Tejani, and Ki Hyeong Lee.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage III
2Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
Fouad M. HajjarAdventHealth Orlando8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
46 reported clinical trials
89 drugs studied
Carlos AlemanyAdventHealth Orlando6 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
22 reported clinical trials
62 drugs studied
Mohamedtaki A. TejaniAdventHealth Orlando4 years of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
18 reported clinical trials
35 drugs studied
Ki Hyeong LeeChungbuk National University Hospital2 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
26 drugs studied
Clinical Trials running at AdventHealth Orlando
Breast Cancer
Non-Hodgkin's Lymphoma
Lung Cancer
Cancer
Testicular cancer
Pancreatic Cancer
Ovarian Cancer
B-Cell Lymphoma
Prostate Cancer
Breast cancer
Bria-IMT + CPI
for Advanced Breast Cancer
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.
Recruiting2 awards Phase 36 criteria
PF-07220060 + Letrozole
for Breast Cancer
The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people with breast cancer: * HR-positive (breast cancer cells that need estrogen or progesterone to grow) * HER2-negative (cells that have a small amount or none of a protein called HER2 on their surface); * locally advanced (that has spread from where it started to nearby tissue or lymph nodes) or metastatic disease (the spread of cancer to other places in the body) * who have not received any prior systemic anti-cancer treatment for advanced/metastatic disease. Approximately half of the participants will receive PF-07220060 plus letrozole while the other half of participants will receive the investigator's choice of treatment plus letrozole. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.
Recruiting2 awards Phase 34 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at AdventHealth Orlando?
AdventHealth Orlando is a medical facility located in Orlando, Florida. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Brain Tumor, Ovarian Cancer and other specialties. AdventHealth Orlando is involved with conducting 658 clinical trials across 903 conditions. There are 43 research doctors associated with this hospital, such as Fouad M. Hajjar, Carlos Alemany, Mohamedtaki A. Tejani, and Ki Hyeong Lee.
Where is AdventHealth Orlando located?
**AdventHealth Orlando**
- **Address:** 601 E Rollins St, Orlando, FL 32803
- **Location:** Conveniently located near downtown Orlando, close to major highways and public transportation options.
- **Parking:** Free garage parking available; valet service offered for a fee.
Who should I call to ask about financial aid or insurance network?
For financial assistance at AdventHealth Orlando, please call 407-303-5600. For inquiries about the application process, contact the financial counseling department at 844-652-0600. Further information is available by selecting a specific location on the AdventHealth website.
What insurance does AdventHealth Orlando accept?
AdventHealth Orlando accepts a wide range of insurance plans, including, but not limited to, Aetna, AvMed, Blue Cross & Blue Shield of Florida, Cigna, Humana, and Molina Healthcare of Florida. Coverage types include HMO, PPO, Medicaid, Medicare, and Work Comp. It's recommended to call in advance to confirm if your plan is accepted.
What awards or recognition has AdventHealth Orlando received?
AdventHealth Orlando, located in Orlando, Florida, is renowned for its exceptional research and care, earning numerous accolades. It is accredited as a Community Comprehensive Cancer Center by the American College of Surgeons Commission on Cancer and recognized for quality and innovation by the American Society of Clinical Oncology. The AdventHealth Research Institute leads in research, conducting over 690 studies in 2021, and maintains partnerships with prestigious organizations such as the National Cancer Institute, Duke Oncology Network, and Sarah Cannon Oncology Research Consortium.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.